Executive Director & VP, Oncology Medical Strategy

ThermoFisher Scientific; Nederland; Híbrido; EUR 180.000 - 320.000; Jornada completa

Ventajas ofrecidas por este puesto de trabajo

Competitive salary

Mentorship and training

Exciting work environment

Descripción de la vacante

Thermo Fisher Scientific in the Netherlands seeks an Executive Director/Vice President for the Medical Science and Strategy Team - Oncology. Based in the EMEA region, the role drives strategic and measurable business outcomes with oncology expertise, travel to China, or relocation considered.

You will lead input into RFPs, provide therapeutic guidance, mentor clinical scientists, and shape development plans for oncology assets across Thermo Fisher Scientific's PPD clinical research portfolio.

Formación

• MD or equivalent required.
• Certified Oncologist with at least 5+ years’ experience in pharmaceutical industry leading clinical development of at least one asset from discovery through registration.
• Proficient in spoken and written English and Mandarin
• Active medical license preferred but not required.

Responsabilidades

• Provide input into RFPs with development strategy, regulatory issues, drug class considerations, and indications.
• Support client engagement and strategic alliance development for oncology assets.
• Provide therapeutic expertise to internal teams and mentorship to clinical scientists.
• Lead multidisciplinary teams and contribute to innovative initiatives in oncology.

Conocimientos

Leadership

Strategic thinking

Communication

English and Mandarin proficiency

Travel flexibility

Educación

MD or equivalent

Descripción del empleo

Thermo Fisher Scientific in the Netherlands seeks an Executive Director/Vice President for the Medical Science and Strategy Team - Oncology. Based in the EMEA region, the role drives strategic and measurable business outcomes with oncology expertise, travel to China, or relocation considered.

You will lead input into RFPs, provide therapeutic guidance, mentor clinical scientists, and shape development plans for oncology assets across Thermo Fisher Scientific's PPD clinical research portfolio.